Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Series/Report no.
RIVM rapport 607880006Type
ReportLanguage
en
Metadata
Show full item recordTitle
Environmental effect indicators for priority pollutantsTranslated Title
Milieueffectindicatoren voor prioritaire stoffenPubliekssamenvatting
Dit rapport beschrijft een methode die de effecten schat van Nederlandse emissies van prioritaire stoffen op de volksgezondheid en ecosystemen. Prioritaire stoffen vormen een dusdanig gevaar voor het milieu, dat met voorrang emissiereducerende maatregelen zijn getroffen om dat gevaar te verminderen. De methode berekent zogenaamde MilieuEffectIndicatoren (MEI) en is ontwikkeld om te toetsen of de doelstellingen van het Nederlandse milieubeleid gehaald zijn.De eerste milieueffectindicator, de MEI/eco, schat het verlies van soorten organismen in het Nederlandse oppervlaktewater als gevolg van emissies van prioritaire stoffen. Uit een toetsing blijkt dat het effect van prioritaire stoffen op de soortensamenstelling in de periode 1990-2003 ongeveer is gehalveerd. Op basis van de Nederlandse emissies wordt het verlies van soorten in 1990 geschat op 3,2% en in 2003 op 1,8%. De MEI/eco wordt berekend op basis van geschatte blootstelling, de gevoeligheid van soorten voor bepaalde stoffen en de giftigheid van bepaalde stofmengsels. De tweede milieueffectindicator, de MEI/vgz, schat het effect van emissies van prioritaire stoffen op de volksgezondheid. Uit een analyse van de situatie in Nederland blijkt dat de impact van de prioritaire stoffen op de volksgezondheid met ongeveer eenderde is afgenomen. Het effect wordt uitgedrukt in het verlies aan DALY's (Disability Adjusted Life Years), ofwel het aantal gezonde levensjaren dat een populatie verliest door ziekten of voortijdig overlijden. Het effect van de Nederlandse emissies wordt geschat op een verlies van 59.000 DALY in 1990 en 42.000 DALY in 2003. De MEI/vgz wordt berekend op basis van geschatte blootstelling, de ziekteverwekkende eigenschappen van bepaalde stoffen en epidemiologische gegevens.
Here a method is described for estimating public health and ecosystem effects due to the emission of priority pollutants in the Netherlands. Priority pollutants are subject to measures of emission reduction because of their immediate threat to the environment. The method proposed calculates so-called environmental effect indicators (MEI in Dutch) and is designed to test the effectiveness of the environmental policy in the Netherlands.
The first indicator, for ecological environmental effect (MEI/eco), estimates the impact of priority pollutant emissions on the relative loss of species from surface waters in the Netherlands. Evaluation of historical data reveals the impact of priority pollutants on the composition of aquatic species was to have approximately halved between 1990 and 2003. When considering only the impact of emissions originating from the Netherlands, the loss of species was estimated at 3.2% in 1990 and 1.8% in 2003. The calculation of the MEI/eco is based on estimated exposure, pollutant-specific species-sensitivity distributions and considerations on mixture toxicity.
The second indicator, the public health effect indicator (MEI/vgz), estimates the impact of priority pollutant emissions on the health of the Dutch population. Evaluation of historical data reveals an impact reduction of approximately one-third of the priority pollutants on public health in the Netherlands between 1990 and 2003. The impact is expressed as the loss of Disability Adjusted Life Years (DALY), which is the population loss of healthy life years due to disease and untimely death. If we consider only the emissions originating from the Netherlands, the health impact is estimated at a loss of 59,000 DALY in 1990 and 41,000 DALY in 2003. The calculation of the MEI/vgz is based on estimated exposure, the pathogenic properties of priority pollutants and epidemiological considerations.
Publisher
Rijksinstituut voor Volksgezondheid en Milieu RIVMVakgroep Milieukunde
Radboud Universiteit
Nijmegen
Sponsors
VROM-DGM-SASCollections
Related items
Showing items related by title, author, creator and subject.
-
Long-term effectiveness and cost-effectiveness of an 18-week supervised exercise program in patients treated with autologous stem cell transplantation: results from the EXIST study.van Dongen, Johanna M; Persoon, Saskia; Jongeneel, Gabrielle; Bosmans, Judith E; Kersten, Marie José; Brug, Johannes; Nollet, Frans; Chinapaw, Mai J M; Buffart, Laurien M (2019-08-01)One hundred nine patients were randomly assigned to the exercise intervention (n = 54) or the usual care control group (n = 55). Data on cardiorespiratory fitness (VO2peak), handgrip strength, general fatigue, and health-related quality of life (quality-adjusted life years [QALYs]) were collected at baseline (T0), after completion of the exercise intervention or at a similar time point in the control group (T1) and 12 months later (T2). Cost questionnaires were used to assess societal costs. Long-term effectiveness (at T2) was evaluated using linear mixed model analyses. For the economic evaluation, missing data were imputed using multiple imputation, and data were analyzed using linear mixed models.
-
The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review.Myran, Daniel T; Morton, Rachael; Biggs, Beverly-Ann; Veldhuijzen, Irene; Castelli, Francesco; Tran, Anh; Staub, Lukas P; Agbata, Eric; Rahman, Prinon; Pareek, Manish; et al. (2018-09-01)Migrants from hepatitis B virus (HBV) endemic countries to the European Union/European Economic Area (EU/EEA) comprise 5.1% of the total EU/EEA population but account for 25% of total chronic Hepatitis B (CHB) infection. Migrants from high HBV prevalence regions are at the highest risk for CHB morbidity. These migrants are at risk of late detection of CHB complications; mortality and onwards transmission. The aim of this systematic review is to evaluate the effectiveness and cost-effectiveness of CHB screening and vaccination programs among migrants to the EU/EEA. We found no RCTs or direct evidence evaluating the effectiveness of CHB screening on morbidity and mortality of migrants. We therefore used a systematic evidence chain approach to identify studies relevant to screening and prevention programs; testing, treatment, and vaccination. We identified four systematic reviews and five additional studies and guidelines that reported on screening and vaccination effectiveness. Studies reported that vaccination programs were highly effective at reducing the prevalence of CHB in children (RR 0.07 95% CI 0.04 to 0.13) following vaccination. Two meta-analyses of therapy for chronic HBV infection found improvement in clinical outcomes and intermediate markers of disease. We identified nine studies examining the cost-effectiveness of screening for CHB: a strategy of screening and treating CHB compared to no screening. The median acceptance of HB screening was 87.4% (range 32.3⁻100%). Multiple studies highlighted barriers to and the absence of effective strategies to ensure linkage of treatment and care for migrants with CHB. In conclusion, screening of high-risk children and adults and vaccination of susceptible children, combined with treatment of CHB infection in migrants, are promising and cost-effective interventions, but linkage to treatment requires more attention.
-
The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness - A systematic review.Hughes, Stephanie L; Bolotin, Shelly; Khan, Sumaiya; Li, Ye; Johnson, Caitlin; Friedman, Lindsay; Tricco, Andrea C; Hahné, Susan J M; Heffernan, Jane M; Dabbagh, Alya; et al. (2019-11-12)